nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Personality disorder—Carmustine—melanoma	0.0169	0.0504	CcSEcCtD
Levorphanol—Hypokinesia—Carmustine—melanoma	0.0108	0.0323	CcSEcCtD
Levorphanol—Thinking abnormal—Carmustine—melanoma	0.008	0.0238	CcSEcCtD
Levorphanol—Injection site reaction—Carmustine—melanoma	0.00728	0.0217	CcSEcCtD
Levorphanol—Respiratory failure—Temozolomide—melanoma	0.0072	0.0214	CcSEcCtD
Levorphanol—Coma—Carmustine—melanoma	0.00669	0.0199	CcSEcCtD
Levorphanol—Abnormal vision—Carmustine—melanoma	0.00638	0.019	CcSEcCtD
Levorphanol—Mental disability—Carmustine—melanoma	0.00635	0.0189	CcSEcCtD
Levorphanol—Abnormal vision—Temozolomide—melanoma	0.00617	0.0184	CcSEcCtD
Levorphanol—Mental disability—Temozolomide—melanoma	0.00614	0.0183	CcSEcCtD
Levorphanol—Lethargy—Dactinomycin—melanoma	0.00579	0.0173	CcSEcCtD
Levorphanol—Amnesia—Carmustine—melanoma	0.00566	0.0168	CcSEcCtD
Levorphanol—Amnesia—Temozolomide—melanoma	0.00547	0.0163	CcSEcCtD
Levorphanol—Diplopia—Carmustine—melanoma	0.00531	0.0158	CcSEcCtD
Levorphanol—Diplopia—Temozolomide—melanoma	0.00514	0.0153	CcSEcCtD
Levorphanol—Affect lability—Temozolomide—melanoma	0.00505	0.015	CcSEcCtD
Levorphanol—Mood swings—Temozolomide—melanoma	0.00486	0.0145	CcSEcCtD
Levorphanol—Respiratory failure—Docetaxel—melanoma	0.00479	0.0143	CcSEcCtD
Levorphanol—Injection site reaction—Docetaxel—melanoma	0.00468	0.0139	CcSEcCtD
Levorphanol—Hypotension—Vemurafenib—melanoma	0.00461	0.0137	CcSEcCtD
Levorphanol—Constipation—Vemurafenib—melanoma	0.00422	0.0126	CcSEcCtD
Levorphanol—Dysuria—Temozolomide—melanoma	0.00415	0.0124	CcSEcCtD
Levorphanol—Estrone—CYP1B1—melanoma	0.00405	0.29	CrCbGaD
Levorphanol—Renal failure—Carmustine—melanoma	0.00403	0.012	CcSEcCtD
Levorphanol—Flushing—Bleomycin—melanoma	0.00391	0.0116	CcSEcCtD
Levorphanol—Flushing—Dactinomycin—melanoma	0.00365	0.0109	CcSEcCtD
Levorphanol—Visual impairment—Carmustine—melanoma	0.00354	0.0105	CcSEcCtD
Levorphanol—Pruritus—Vemurafenib—melanoma	0.00349	0.0104	CcSEcCtD
Levorphanol—Lethargy—Docetaxel—melanoma	0.00348	0.0104	CcSEcCtD
Levorphanol—Visual impairment—Temozolomide—melanoma	0.00342	0.0102	CcSEcCtD
Levorphanol—Flushing—Carmustine—melanoma	0.00341	0.0102	CcSEcCtD
Levorphanol—Flushing—Temozolomide—melanoma	0.0033	0.00982	CcSEcCtD
Levorphanol—Arrhythmia—Carmustine—melanoma	0.00328	0.00978	CcSEcCtD
Levorphanol—Dizziness—Vemurafenib—melanoma	0.00327	0.00972	CcSEcCtD
Levorphanol—Vomiting—Vemurafenib—melanoma	0.00314	0.00935	CcSEcCtD
Levorphanol—Rash—Vemurafenib—melanoma	0.00311	0.00927	CcSEcCtD
Levorphanol—Dermatitis—Vemurafenib—melanoma	0.00311	0.00926	CcSEcCtD
Levorphanol—Estradiol—CYP1B1—melanoma	0.00307	0.22	CrCbGaD
Levorphanol—Confusional state—Bleomycin—melanoma	0.00302	0.00898	CcSEcCtD
Levorphanol—Agitation—Carmustine—melanoma	0.00294	0.00876	CcSEcCtD
Levorphanol—Nausea—Vemurafenib—melanoma	0.00293	0.00873	CcSEcCtD
Levorphanol—Agitation—Temozolomide—melanoma	0.00284	0.00846	CcSEcCtD
Levorphanol—Hypotension—Bleomycin—melanoma	0.0028	0.00832	CcSEcCtD
Levorphanol—Convulsion—Carmustine—melanoma	0.00277	0.00826	CcSEcCtD
Levorphanol—Palpitations—Temozolomide—melanoma	0.00273	0.00814	CcSEcCtD
Levorphanol—Convulsion—Temozolomide—melanoma	0.00268	0.00798	CcSEcCtD
Levorphanol—Confusional state—Carmustine—melanoma	0.00263	0.00784	CcSEcCtD
Levorphanol—Renal failure—Docetaxel—melanoma	0.00259	0.0077	CcSEcCtD
Levorphanol—Dry mouth—Temozolomide—melanoma	0.00257	0.00767	CcSEcCtD
Levorphanol—Tachycardia—Carmustine—melanoma	0.00255	0.00759	CcSEcCtD
Levorphanol—Confusional state—Temozolomide—melanoma	0.00254	0.00758	CcSEcCtD
Levorphanol—Feeling abnormal—Bleomycin—melanoma	0.00247	0.00734	CcSEcCtD
Levorphanol—Hypotension—Carmustine—melanoma	0.00244	0.00727	CcSEcCtD
Levorphanol—Hyperhidrosis—Temozolomide—melanoma	0.00244	0.00726	CcSEcCtD
Levorphanol—Urticaria—Bleomycin—melanoma	0.00238	0.00708	CcSEcCtD
Levorphanol—Insomnia—Carmustine—melanoma	0.00236	0.00703	CcSEcCtD
Levorphanol—Feeling abnormal—Dactinomycin—melanoma	0.0023	0.00685	CcSEcCtD
Levorphanol—Insomnia—Temozolomide—melanoma	0.00228	0.0068	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dactinomycin—melanoma	0.00228	0.00679	CcSEcCtD
Levorphanol—Visual impairment—Docetaxel—melanoma	0.00228	0.00678	CcSEcCtD
Levorphanol—Constipation—Carmustine—melanoma	0.00223	0.00665	CcSEcCtD
Levorphanol—Dyspepsia—Temozolomide—melanoma	0.00222	0.00662	CcSEcCtD
Levorphanol—Abdominal pain—Dactinomycin—melanoma	0.00221	0.00657	CcSEcCtD
Levorphanol—Flushing—Docetaxel—melanoma	0.00219	0.00653	CcSEcCtD
Levorphanol—Constipation—Temozolomide—melanoma	0.00216	0.00643	CcSEcCtD
Levorphanol—Feeling abnormal—Carmustine—melanoma	0.00215	0.00641	CcSEcCtD
Levorphanol—Gastrointestinal pain—Carmustine—melanoma	0.00214	0.00636	CcSEcCtD
Levorphanol—Pruritus—Bleomycin—melanoma	0.00212	0.0063	CcSEcCtD
Levorphanol—Arrhythmia—Docetaxel—melanoma	0.00211	0.00628	CcSEcCtD
Levorphanol—Feeling abnormal—Temozolomide—melanoma	0.00208	0.00619	CcSEcCtD
Levorphanol—Abdominal pain—Carmustine—melanoma	0.00206	0.00615	CcSEcCtD
Levorphanol—Gastrointestinal pain—Temozolomide—melanoma	0.00206	0.00615	CcSEcCtD
Levorphanol—Urticaria—Temozolomide—melanoma	0.00201	0.00597	CcSEcCtD
Levorphanol—Abdominal pain—Temozolomide—melanoma	0.002	0.00594	CcSEcCtD
Levorphanol—Muscle spasms—Docetaxel—melanoma	0.00198	0.00589	CcSEcCtD
Levorphanol—Vomiting—Bleomycin—melanoma	0.0019	0.00566	CcSEcCtD
Levorphanol—Rash—Bleomycin—melanoma	0.00189	0.00562	CcSEcCtD
Levorphanol—Dermatitis—Bleomycin—melanoma	0.00188	0.00561	CcSEcCtD
Levorphanol—Palpitations—Docetaxel—melanoma	0.00182	0.00541	CcSEcCtD
Levorphanol—Pruritus—Temozolomide—melanoma	0.00179	0.00532	CcSEcCtD
Levorphanol—Convulsion—Docetaxel—melanoma	0.00178	0.00531	CcSEcCtD
Levorphanol—Nausea—Bleomycin—melanoma	0.00178	0.00529	CcSEcCtD
Levorphanol—Vomiting—Dactinomycin—melanoma	0.00177	0.00528	CcSEcCtD
Levorphanol—Rash—Dactinomycin—melanoma	0.00176	0.00524	CcSEcCtD
Levorphanol—Dizziness—Carmustine—melanoma	0.00173	0.00514	CcSEcCtD
Levorphanol—Dry mouth—Docetaxel—melanoma	0.00171	0.0051	CcSEcCtD
Levorphanol—Confusional state—Docetaxel—melanoma	0.00169	0.00504	CcSEcCtD
Levorphanol—Dizziness—Temozolomide—melanoma	0.00167	0.00497	CcSEcCtD
Levorphanol—Vomiting—Carmustine—melanoma	0.00166	0.00494	CcSEcCtD
Levorphanol—Nausea—Dactinomycin—melanoma	0.00166	0.00494	CcSEcCtD
Levorphanol—Shock—Docetaxel—melanoma	0.00165	0.00492	CcSEcCtD
Levorphanol—Rash—Carmustine—melanoma	0.00165	0.0049	CcSEcCtD
Levorphanol—Dermatitis—Carmustine—melanoma	0.00165	0.0049	CcSEcCtD
Levorphanol—Tachycardia—Docetaxel—melanoma	0.00164	0.00488	CcSEcCtD
Levorphanol—Vomiting—Temozolomide—melanoma	0.0016	0.00478	CcSEcCtD
Levorphanol—Rash—Temozolomide—melanoma	0.00159	0.00474	CcSEcCtD
Levorphanol—Dermatitis—Temozolomide—melanoma	0.00159	0.00473	CcSEcCtD
Levorphanol—Hypotension—Docetaxel—melanoma	0.00157	0.00467	CcSEcCtD
Levorphanol—Nausea—Carmustine—melanoma	0.00155	0.00462	CcSEcCtD
Levorphanol—Insomnia—Docetaxel—melanoma	0.00152	0.00452	CcSEcCtD
Levorphanol—Nausea—Temozolomide—melanoma	0.0015	0.00446	CcSEcCtD
Levorphanol—Dyspepsia—Docetaxel—melanoma	0.00148	0.0044	CcSEcCtD
Levorphanol—Morphine—ABCB1—melanoma	0.00144	0.103	CrCbGaD
Levorphanol—Constipation—Docetaxel—melanoma	0.00144	0.00427	CcSEcCtD
Levorphanol—Feeling abnormal—Docetaxel—melanoma	0.00138	0.00412	CcSEcCtD
Levorphanol—Gastrointestinal pain—Docetaxel—melanoma	0.00137	0.00409	CcSEcCtD
Levorphanol—Abdominal pain—Docetaxel—melanoma	0.00133	0.00395	CcSEcCtD
Levorphanol—Estrone—ALB—melanoma	0.00122	0.0873	CrCbGaD
Levorphanol—Dextromethorphan—ABCB1—melanoma	0.00121	0.0868	CrCbGaD
Levorphanol—Pruritus—Docetaxel—melanoma	0.00119	0.00354	CcSEcCtD
Levorphanol—Estrone—ABCB1—melanoma	0.00116	0.0833	CrCbGaD
Levorphanol—Dizziness—Docetaxel—melanoma	0.00111	0.0033	CcSEcCtD
Levorphanol—Vomiting—Docetaxel—melanoma	0.00107	0.00318	CcSEcCtD
Levorphanol—Rash—Docetaxel—melanoma	0.00106	0.00315	CcSEcCtD
Levorphanol—Dermatitis—Docetaxel—melanoma	0.00106	0.00315	CcSEcCtD
Levorphanol—Nausea—Docetaxel—melanoma	0.000997	0.00297	CcSEcCtD
Levorphanol—Estradiol—ALB—melanoma	0.000924	0.0662	CrCbGaD
Levorphanol—Estradiol—ABCB1—melanoma	0.000881	0.0631	CrCbGaD
Levorphanol—OPRK1—Signaling Pathways—GNAQ—melanoma	0.000256	0.000394	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—F2R—melanoma	0.000255	0.000392	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SOCS1—melanoma	0.00025	0.000384	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAP2K1—melanoma	0.000249	0.000383	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—S100B—melanoma	0.000249	0.000383	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CD—melanoma	0.000247	0.00038	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RAC1—melanoma	0.000247	0.00038	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—melanoma	0.000247	0.000379	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDNRB—melanoma	0.000247	0.000379	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SYK—melanoma	0.000241	0.00037	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTK2B—melanoma	0.000239	0.000368	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CD—melanoma	0.000239	0.000367	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB4—melanoma	0.000238	0.000366	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CB—melanoma	0.000237	0.000365	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ITGAV—melanoma	0.000236	0.000364	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT3—melanoma	0.000236	0.000364	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NGFR—melanoma	0.000236	0.000364	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN2B—melanoma	0.000236	0.000363	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GAB2—melanoma	0.000233	0.000358	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNA11—melanoma	0.000233	0.000358	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FLT1—melanoma	0.000232	0.000357	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	0.00023	0.000353	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD86—melanoma	0.000228	0.000351	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—melanoma	0.000228	0.000351	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDN1—melanoma	0.000226	0.000348	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF1—melanoma	0.000221	0.00034	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CSF2—melanoma	0.000221	0.00034	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCR4—melanoma	0.000219	0.000337	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HDAC2—melanoma	0.000219	0.000337	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FOXO4—melanoma	0.000219	0.000337	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SOCS1—melanoma	0.000219	0.000337	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAP2K1—melanoma	0.000218	0.000336	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—S100B—melanoma	0.000218	0.000336	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—melanoma	0.000218	0.000335	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—melanoma	0.000217	0.000334	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—E2F1—melanoma	0.000217	0.000333	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNAQ—melanoma	0.000216	0.000333	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—melanoma	0.000216	0.000332	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFRA—melanoma	0.000214	0.00033	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ITGB3—melanoma	0.000212	0.000326	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCA—melanoma	0.000212	0.000326	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB4—melanoma	0.000209	0.000321	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—melanoma	0.000209	0.000321	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—melanoma	0.000208	0.00032	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SPP1—melanoma	0.000208	0.00032	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP2K2—melanoma	0.000207	0.000319	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—melanoma	0.000207	0.000319	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN2B—melanoma	0.000207	0.000318	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SYK—melanoma	0.000204	0.000313	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	0.000202	0.00031	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD86—melanoma	0.0002	0.000308	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—melanoma	0.0002	0.000308	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT3—melanoma	0.0002	0.000307	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ITGAV—melanoma	0.0002	0.000307	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NGFR—melanoma	0.0002	0.000307	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDN1—melanoma	0.000199	0.000305	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—melanoma	0.000198	0.000305	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—melanoma	0.000197	0.000303	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RAC1—melanoma	0.000197	0.000303	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CSF2—melanoma	0.000194	0.000299	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF1—melanoma	0.000194	0.000299	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—melanoma	0.000191	0.000294	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—E2F1—melanoma	0.00019	0.000292	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—melanoma	0.000189	0.000291	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—melanoma	0.000189	0.00029	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFRA—melanoma	0.000188	0.000289	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ITGB3—melanoma	0.000186	0.000286	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCA—melanoma	0.000186	0.000286	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SOCS1—melanoma	0.000185	0.000284	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAP2K1—melanoma	0.000185	0.000284	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—S100B—melanoma	0.000184	0.000284	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—melanoma	0.000183	0.000282	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SPP1—melanoma	0.000182	0.000281	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP2K2—melanoma	0.000182	0.00028	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—melanoma	0.000182	0.000279	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—melanoma	0.00018	0.000278	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB4—melanoma	0.000176	0.000271	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	0.000176	0.000271	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN2B—melanoma	0.000175	0.000269	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FN1—melanoma	0.000174	0.000267	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—melanoma	0.000174	0.000267	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—melanoma	0.000173	0.000266	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RAC1—melanoma	0.000173	0.000265	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH1—melanoma	0.00017	0.000261	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD86—melanoma	0.000169	0.00026	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—melanoma	0.000169	0.00026	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDN1—melanoma	0.000168	0.000258	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CD80—melanoma	0.000167	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APC—melanoma	0.000166	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—melanoma	0.000166	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KIT—melanoma	0.000166	0.000256	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—NRAS—melanoma	0.000166	0.000256	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—melanoma	0.000165	0.000254	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGF—melanoma	0.000164	0.000253	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CSF2—melanoma	0.000164	0.000252	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF1—melanoma	0.000164	0.000252	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—melanoma	0.000162	0.000249	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—E2F1—melanoma	0.000161	0.000247	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—melanoma	0.00016	0.000246	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK3—melanoma	0.000159	0.000245	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFRA—melanoma	0.000159	0.000244	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—melanoma	0.000158	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCA—melanoma	0.000157	0.000242	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ITGB3—melanoma	0.000157	0.000242	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BRAF—melanoma	0.000156	0.00024	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SPP1—melanoma	0.000154	0.000237	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP2K2—melanoma	0.000154	0.000236	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—melanoma	0.000154	0.000236	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FN1—melanoma	0.000152	0.000234	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—melanoma	0.000152	0.000234	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK1—melanoma	0.000151	0.000233	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—melanoma	0.000151	0.000233	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH1—melanoma	0.000149	0.000229	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP2K1—melanoma	0.000147	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—melanoma	0.000147	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—melanoma	0.000146	0.000225	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—melanoma	0.000146	0.000225	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CD80—melanoma	0.000146	0.000225	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RAC1—melanoma	0.000146	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APC—melanoma	0.000146	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—melanoma	0.000146	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KIT—melanoma	0.000146	0.000224	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—NRAS—melanoma	0.000146	0.000224	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	0.000145	0.000223	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGF—melanoma	0.000144	0.000222	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—melanoma	0.000143	0.00022	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF2—melanoma	0.00014	0.000215	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—melanoma	0.00014	0.000215	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK3—melanoma	0.00014	0.000215	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BRAF—melanoma	0.000137	0.000211	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—melanoma	0.000134	0.000206	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—melanoma	0.000133	0.000205	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK1—melanoma	0.000133	0.000204	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—melanoma	0.000133	0.000204	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—melanoma	0.000131	0.000202	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MDM2—melanoma	0.000131	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB2—melanoma	0.000129	0.000198	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP2K1—melanoma	0.000129	0.000198	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FN1—melanoma	0.000129	0.000198	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—melanoma	0.000128	0.000197	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—melanoma	0.000127	0.000196	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	0.000127	0.000195	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH1—melanoma	0.000126	0.000194	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—melanoma	0.000125	0.000193	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CD80—melanoma	0.000123	0.00019	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APC—melanoma	0.000123	0.000189	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KIT—melanoma	0.000123	0.000189	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—melanoma	0.000123	0.000189	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—NRAS—melanoma	0.000123	0.000189	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF2—melanoma	0.000123	0.000189	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—melanoma	0.000122	0.000188	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGF—melanoma	0.000122	0.000187	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HRAS—melanoma	0.000122	0.000187	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1B—melanoma	0.00012	0.000184	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—melanoma	0.000118	0.000182	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK3—melanoma	0.000118	0.000181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—melanoma	0.000117	0.00018	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—melanoma	0.000117	0.00018	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—melanoma	0.000116	0.000179	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BRAF—melanoma	0.000116	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—melanoma	0.000115	0.000177	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MDM2—melanoma	0.000115	0.000177	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—melanoma	0.000114	0.000175	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB2—melanoma	0.000113	0.000174	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CTNNB1—melanoma	0.000113	0.000174	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—melanoma	0.000113	0.000173	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK1—melanoma	0.000112	0.000173	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—melanoma	0.000112	0.000173	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—melanoma	0.000112	0.000172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—melanoma	0.000111	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1A—melanoma	0.00011	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—melanoma	0.00011	0.000169	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKB1—melanoma	0.00011	0.000168	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP2K1—melanoma	0.000109	0.000168	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—melanoma	0.000108	0.000167	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—melanoma	0.000107	0.000165	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—melanoma	0.000107	0.000165	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	0.000107	0.000165	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HRAS—melanoma	0.000107	0.000164	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—melanoma	0.000106	0.000163	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1B—melanoma	0.000105	0.000161	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF2—melanoma	0.000104	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—melanoma	0.000104	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—melanoma	0.000103	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—melanoma	0.000103	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—melanoma	0.000102	0.000157	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—melanoma	0.0001	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—melanoma	9.94e-05	0.000153	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CTNNB1—melanoma	9.9e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—melanoma	9.84e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NRAS—melanoma	9.82e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—melanoma	9.74e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—melanoma	9.71e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MDM2—melanoma	9.7e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1A—melanoma	9.67e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—melanoma	9.65e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKB1—melanoma	9.6e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB2—melanoma	9.56e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—melanoma	9.44e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—melanoma	9.41e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK3—melanoma	9.4e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—melanoma	9.15e-05	0.000141	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—melanoma	9.07e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HRAS—melanoma	9.01e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK1—melanoma	8.95e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—melanoma	8.95e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1B—melanoma	8.86e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—melanoma	8.76e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—melanoma	8.72e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—melanoma	8.68e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—melanoma	8.67e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—melanoma	8.63e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—melanoma	8.63e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRAS—melanoma	8.61e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—melanoma	8.45e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—melanoma	8.45e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CTNNB1—melanoma	8.37e-05	0.000129	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK3—melanoma	8.25e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—melanoma	8.2e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1A—melanoma	8.17e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—melanoma	8.16e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKB1—melanoma	8.12e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—melanoma	8.02e-05	0.000123	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—melanoma	7.96e-05	0.000122	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK1—melanoma	7.85e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—melanoma	7.84e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—melanoma	7.76e-05	0.000119	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—melanoma	7.51e-05	0.000116	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—melanoma	7.41e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—melanoma	7.37e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—melanoma	7.29e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRAS—melanoma	7.28e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HRAS—melanoma	7.18e-05	0.00011	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK3—melanoma	6.97e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—melanoma	6.88e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—melanoma	6.81e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—melanoma	6.78e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK1—melanoma	6.63e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—melanoma	6.63e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—melanoma	6.59e-05	0.000101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—melanoma	6.34e-05	9.76e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRAS—melanoma	6.3e-05	9.69e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—melanoma	6.26e-05	9.63e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—melanoma	6.03e-05	9.27e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—melanoma	5.75e-05	8.85e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—melanoma	5.57e-05	8.56e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—melanoma	5.56e-05	8.55e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRAS—melanoma	5.32e-05	8.19e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—melanoma	5.1e-05	7.84e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—melanoma	4.7e-05	7.23e-05	CbGpPWpGaD
